8-K - Vanda Pharmaceuticals Inc. - 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001628280-26-026642
Filing Date: 2026-04-22
Accepted: 2026-04-22 17:23:06
Documents: 13
Period of Report: 2026-04-22
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Vanda Pharmaceuticals Inc. (Filer) CIK : 0001347178 (see all company filings) EIN. : 030491827 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 26884802 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | vnda-20260422.htm iXBRL | 8-K
2 | EX-99.1 | vnda8-k4222026exhibit991.htm | EX-99.1
6 | vandaq32019earningsca_imag.jpg | GRAPHIC | 49643
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vnda-20260422.xsd | EX-101.SCH